Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Guyana.
Press releases published on September 15, 2025
Genius Group executes buyback of one million shares, increases company shares in book entry to 60.3%
SINGAPORE, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that the Company bought back one million shares of its stock on …
Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced the appointment of …
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although clinical benefit for efzofitimod observed across multiple study parameters. 52.6% of patients treated with 5.0 mg/kg efzofitimod …
Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
MELBOURNE, Australia and SAN FRANCISCO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …
HALA raises $157m in one of the Middle East’s largest fintech Series B rounds, led by TPG and Sanabil Investments
Riyadh, Sept. 15, 2025 (GLOBE NEWSWIRE) -- HALA, Saudi Arabia’s leading fintech and provider of embedded financial services to micro, small and medium enterprises, has raised $157 million in a Series B investment round — officially one of the largest …
Atavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical Officer
Dr. Pandya brings 20 years of drug development expertise in precision medicine in both oncology and hematology, with previous senior leadership roles at Servier Pharmaceuticals and Agios Pharmaceuticals Her appointment follows Atavistik Bio’s recent …
Verano Holdings Corp. Announces Proposed Redomicile of Parent Company from British Columbia to Nevada
CHICAGO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that the Company’s Board of Directors approved, and the Company will be …
Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases
Novartis receives an exclusive license to an undisclosed discovery target Novartis also receives options to license two programs from Monte Rosa’s growing preclinical immunology portfolio Monte Rosa to receive an upfront payment of $120 million, plus …
Humacyte Announces Publication of Outcomes for Patients with Hospital-Acquired Vascular Complications Treated with Symvess™
- Results were published in the Journal of Vascular Surgery - - Publication described treatment of patients with Symvess who had hospital-acquired iatrogenic injuries or complications of vascular surgical procedures - - Patients treated with Symvess were …
Forterra and Volvo Defense Demonstrate Integrated Autonomous Mission Systems in Vehicle Platforms
Washington, D.C., Sept. 15, 2025 (GLOBE NEWSWIRE) -- U.S.-based autonomy leader Forterra and Volvo Defense, a business operation within Volvo Trucks, are showcasing a solution to integrate Forterra’s mission systems into Volvo’s proven transport vehicles, …
Can-Fite Reports Complete Resolution of Esophageal Varices in Decompensated Cirrhosis Patient Treated with Namodenoson
Ramat Gan, Israel, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …
Descartes’ 9th Annual Study Finds Transportation Management Reaches Record Strategic Importance
81% of shippers and logistics services providers view transportation as a competitive weapon; growth and AI adoption driving investments despite automation gap LONDON and ATLANTA, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) ( …
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
Upfront fees and near-term development milestone payments totaling up to $7.5 million Potential sales milestones of $180 million or more in first 10 years of commercialization Royalties equaling 25% of net sales Ocugen to manufacture and supply OCU400 …
Digital Gold ($GOLD) Officially Launches on Solana, Hits $1.8M Market Cap on Day One
BERN, Switzerland, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Digital Gold ($GOLD) is proud to announce its official launch on the Solana blockchain. Debuting through Pump.fun, $GOLD reached a $1.8 million market cap within its first 24 hours, accompanied by …
Bitcoin Holds at $116K, Cardano Awaits ETF Decision, BullZilla Advances in September 2025 Presale
LONDON, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The crypto market in late 2025 is experiencing pivotal developments. Bitcoin is consolidating at $116,000, Cardano is moving toward clarity on a potential ETF approval, and BullZilla’s presale is progressing …
Tomorrow.City Shanghai 2025 Dibuka, Menyoroti Inovasi Kota Pintar Global
SHANGHAI, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Tomorrow.City Shanghai (TCS 2025) telah dibuka di Balai Sains Zhangjiang dengan tema “Tantangan dan Solusi”. Dengan skala yang lebih ditingkatkan, TCS 2025 menyambut para delegasi dari lebih 110 kota di Asia, …
Tomorrow.City Shanghai 2025 Dibuka, Menjadi Tumpuan Inovasi Bandar Pintar Global
SHANGHAI, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Tomorrow.City Shanghai 2025 (TCS 2025) telah membuka tirainya di Zhangjiang Science Hall dengan tema “Cabaran dan Penyelesaian”. Dengan skala yang diperluas, TCS 2025 telah mengalu-alukan delegasi dari lebih 110 …
Sự kiện ra mắt Tomorrow.City Shanghai 2025, đánh dấu kỷ nguyên mới của đô thị thông minh toàn cầu
SHANGHAI, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Tomorrow.City Shanghai (TCS 2025) đã ra mắt tại Trung tâm hội nghị Zhangjiang Science Hall với chủ đề “Thách thức và Giải pháp”. Với quy mô rộng lớn, TCS 2025 đã chào đón các đại biểu đến từ hơn 110 thành phố …